{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T05:28:12Z","timestamp":1782278892269,"version":"3.54.5"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,4,5]],"date-time":"2016-04-05T00:00:00Z","timestamp":1459814400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Establishing the Dutch National Registry of Growth Hormone Treatment in Adults was financed by the Health Care Insurance Board."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1007\/s11102-016-0716-3","type":"journal-article","created":{"date-parts":[[2016,4,5]],"date-time":"2016-04-05T10:15:29Z","timestamp":1459851329000},"page":"381-390","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Fractures in pituitary adenoma patients from the Dutch National Registry of Growth Hormone Treatment in Adults"],"prefix":"10.1007","volume":"19","author":[{"given":"N. C.","family":"van Varsseveld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. C.","family":"van Bunderen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. A. M.","family":"Franken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. P. F.","family":"Koppeschaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. J.","family":"van der Lely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. L.","family":"Drent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,5]]},"reference":[{"issue":"2","key":"716_CR1","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1210\/jcem.83.2.4594","volume":"83","author":"PV Carroll","year":"1998","unstructured":"Carroll PV, Christ ER, Bengtsson BA, Carlsson L, Christiansen JS, Clemmons D, Hintz R, Ho K, Laron Z, Sizonenko P, Sonksen PH, Tanaka T, Thorne M (1998) Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. J Clin Endocrinol Metab 83(2):382\u2013395","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"716_CR2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1210\/er.16.1.63","volume":"16","author":"H Boer de","year":"1995","unstructured":"de Boer H, Blok GJ, van der Veen EA (1995) Clinical aspects of growth hormone deficiency in adults. Endocr Rev 16(1):63\u201386","journal-title":"Endocr Rev"},{"issue":"1","key":"716_CR3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-2265.1994.tb02452.x","volume":"40","author":"T Rosen","year":"1994","unstructured":"Rosen T, Wiren L, Wilhelmsen L, Wiklund I, Bengtsson BA (1994) Decreased psychological well-being in adult patients with growth hormone deficiency. Clin Endocrinol (Oxf) 40(1):111\u2013116","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"716_CR4","first-page":"55","volume":"19","author":"C Ohlsson","year":"1998","unstructured":"Ohlsson C, Bengtsson BA, Isaksson OG, Andreassen TT, Slootweg MC (1998) Growth hormone and bone. Endocr Rev 19(1):55\u201379","journal-title":"Endocr Rev"},{"issue":"1","key":"716_CR5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ecl.2014.10.014","volume":"44","author":"G Mazziotti","year":"2015","unstructured":"Mazziotti G, Chiavistelli S, Giustina A (2015) Pituitary diseases and bone. Endocrinol Metab Clin North Am 44(1):171\u2013180","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"5","key":"716_CR6","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1210\/er.2007-0036","volume":"29","author":"A Giustina","year":"2008","unstructured":"Giustina A, Mazziotti G, Canalis E (2008) Growth hormone, insulin-like growth factors, and the skeleton. Endocr Rev 29(5):535\u2013559","journal-title":"Endocr Rev"},{"issue":"6","key":"716_CR7","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/MED.0b013e3283319e6d","volume":"16","author":"NA Tritos","year":"2009","unstructured":"Tritos NA, Biller BM (2009) Growth hormone and bone. Curr Opin Endocrinol Diabetes Obes 16(6):415\u2013422","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"2","key":"716_CR8","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1359\/jbmr.2001.16.2.398","volume":"16","author":"C Wuster","year":"2001","unstructured":"Wuster C, Abs R, Bengtsson BA, Bennmarker H, Feldt-Rasmussen U, Hernberg-Stahl E, Monson JP, Westberg B, Wilton P (2001) The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density. J Bone Miner Res 16(2):398\u2013405","journal-title":"J Bone Miner Res"},{"issue":"3","key":"716_CR9","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1530\/eje.0.1370240","volume":"137","author":"T Rosen","year":"1997","unstructured":"Rosen T, Wilhelmsen L, Landin-Wilhelmsen K, Lappas G, Bengtsson BA (1997) Increased fracture frequency in adult patients with hypopituitarism and GH deficiency. Eur J Endocrinol 137(3):240\u2013245","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"716_CR10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1046\/j.0300-0664.2001.01464.x","volume":"56","author":"P Vestergaard","year":"2002","unstructured":"Vestergaard P, Jorgensen JO, Hagen C, Hoeck HC, Laurberg P, Rejnmark L, Brixen K, Weeke J, Andersen M, Conceicao FL, Nielsen TL, Mosekilde L (2002) Fracture risk is increased in patients with GH deficiency or untreated prolactinomas\u2014a case-control study. Clin Endocrinol (Oxf) 56(2):159\u2013167","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"716_CR11","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1530\/EJE-11-1072","volume":"166","author":"M Elbornsson","year":"2012","unstructured":"Elbornsson M, Gotherstrom G, Bosaeus I, Bengtsson BA, Johannsson G, Svensson J (2012) Fifteen years of growth hormone (GH) replacement increases bone mineral density in hypopituitary patients with adult onset GH deficiency. Eur J Endocrinol 166(5):787\u2013795","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"716_CR12","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1210\/jc.2013-3921","volume":"99","author":"M Barake","year":"2014","unstructured":"Barake M, Klibanski A, Tritos NA (2014) Effects of recombinant human growth hormone therapy on bone mineral density in adults with growth hormone deficiency: a meta-analysis. J Clin Endocrinol Metab 99(3):852\u2013860","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"716_CR13","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/cen.12493","volume":"81","author":"NM Appelman-Dijkstra","year":"2014","unstructured":"Appelman-Dijkstra NM, Claessen KM, Hamdy NA, Pereira AM, Biermasz NR (2014) Effects of up to 15\u00a0years of recombinant human GH (rhGH) replacement on bone metabolism in adults with Growth Hormone Deficiency (GHD): The Leiden Cohort Study. Clin Endocrinol (Oxf) 81(5):727\u2013735","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"716_CR14","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S2213-8587(15)00098-4","volume":"3","author":"D Mo","year":"2015","unstructured":"Mo D, Fleseriu M, Qi R, Jia N, Child CJ, Bouillon R, Hardin DS (2015) Fracture risk in adult patients treated with growth hormone replacement therapy for growth hormone deficiency: a prospective observational cohort study. Lancet Diabetes Endocrinol 3(5):331\u2013338","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"716_CR15","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S2213-8587(15)00036-4","volume":"3","author":"A Giustina","year":"2015","unstructured":"Giustina A, Mazziotti G (2015) Growth hormone replacement therapy and fracture risk. Lancet Diabetes Endocrinol 3(5):307\u2013308","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"716_CR16","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1359\/jbmr.060112","volume":"21","author":"G Mazziotti","year":"2006","unstructured":"Mazziotti G, Bianchi A, Bonadonna S, Nuzzo M, Cimino V, Fusco A, De ML, Giustina A (2006) Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy. J Bone Miner Res 21(4):520\u2013528","journal-title":"J Bone Miner Res"},{"issue":"12","key":"716_CR17","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1359\/jbmr.070811","volume":"22","author":"H Holmer","year":"2007","unstructured":"Holmer H, Svensson J, Rylander L, Johannsson G, Rosen T, Bengtsson BA, Thoren M, Hoybye C, Degerblad M, Bramnert M, Hagg E, Engstrom BE, Ekman B, Thorngren KG, Hagmar L, Erfurth EM (2007) Fracture incidence in GH-deficient patients on complete hormone replacement including GH. J Bone Miner Res 22(12):1842\u20131850","journal-title":"J Bone Miner Res"},{"key":"716_CR18","doi-asserted-by":"crossref","unstructured":"Mazziotti G, Doga M, Frara S, Maffezzoni F, Porcelli T, Cerri L, Maroldi R, Giustina A (2015) Incidence of morphometric vertebral fractures in adult patients with growth hormone deficiency. Endocrine","DOI":"10.1007\/s12020-015-0738-z"},{"issue":"6","key":"716_CR19","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1210\/jc.2011-0179","volume":"96","author":"ME Molitch","year":"2011","unstructured":"Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Vance ML (2011) Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(6):1587\u20131609","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"716_CR20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1530\/eje.0.1460067","volume":"146","author":"U Feldt-Rasmussen","year":"2002","unstructured":"Feldt-Rasmussen U, Abs R, Bengtsson BA, Bennmarker H, Bramnert M, Hernberg-Stahl E, Monson JP, Westberg B, Wilton P, Wuster C (2002) Growth hormone deficiency and replacement in hypopituitary patients previously treated for acromegaly or Cushing\u2019s disease. Eur J Endocrinol 146(1):67\u201374","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"716_CR21","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1210\/er.2013-1048","volume":"36","author":"R Pivonello","year":"2015","unstructured":"Pivonello R, De LM, Cozzolino A, Colao A (2015) The treatment of Cushing\u2019s disease. Endocr Rev 36(4):385\u2013486","journal-title":"Endocr Rev"},{"issue":"2","key":"716_CR22","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s11102-015-0645-6","volume":"18","author":"ST Sharma","year":"2015","unstructured":"Sharma ST, Nieman LK, Feelders RA (2015) Comorbidities in Cushing\u2019s disease. Pituitary 18(2):188\u2013194","journal-title":"Pituitary"},{"issue":"1","key":"716_CR23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1530\/eje.0.1460051","volume":"146","author":"P Vestergaard","year":"2002","unstructured":"Vestergaard P, Lindholm J, Jorgensen JO, Hagen C, Hoeck HC, Laurberg P, Rejnmark L, Brixen K, Kristensen LO, Feldt-Rasmussen U, Mosekilde L (2002) Increased risk of osteoporotic fractures in patients with Cushing\u2019s syndrome. Eur J Endocrinol 146(1):51\u201356","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"716_CR24","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1210\/er.2002-0022","volume":"25","author":"A Colao","year":"2004","unstructured":"Colao A, Ferone D, Marzullo P, Lombardi G (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 25(1):102\u2013152","journal-title":"Endocr Rev"},{"issue":"2","key":"716_CR25","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1210\/jc.2014-2937","volume":"100","author":"G Mazziotti","year":"2015","unstructured":"Mazziotti G, Biagioli E, Maffezzoni F, Spinello M, Serra V, Maroldi R, Floriani I, Giustina A (2015) Bone turnover, bone mineral density, and fracture risk in acromegaly: a meta-analysis. J Clin Endocrinol Metab 100(2):384\u2013394","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"716_CR26","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1210\/jc.2013-2695","volume":"98","author":"KM Claessen","year":"2013","unstructured":"Claessen KM, Kroon HM, Pereira AM, Appelman-Dijkstra NM, Verstegen MJ, Kloppenburg M, Hamdy NA, Biermasz NR (2013) Progression of vertebral fractures despite long-term biochemical control of acromegaly: a prospective follow-up study. J Clin Endocrinol Metab 98(12):4808\u20134815","journal-title":"J Clin Endocrinol Metab"},{"issue":"14","key":"716_CR27","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1056\/NEJM199004053221405","volume":"322","author":"S Melmed","year":"1990","unstructured":"Melmed S (1990) Acromegaly. N Engl J Med 322(14):966\u2013977","journal-title":"N Engl J Med"},{"issue":"2","key":"716_CR28","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00198-003-1531-z","volume":"15","author":"P Vestergaard","year":"2004","unstructured":"Vestergaard P, Mosekilde L (2004) Fracture risk is decreased in acromegaly\u2014a potential beneficial effect of growth hormone. Osteoporos Int 15(2):155\u2013159","journal-title":"Osteoporos Int"},{"issue":"5","key":"716_CR29","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1365-2265.2004.02018.x","volume":"60","author":"G Johannsson","year":"2004","unstructured":"Johannsson G, Sunnerhagen KS, Svensson J (2004) Baseline characteristics and the effects of 2\u00a0years of growth hormone replacement therapy in adults with growth hormone deficiency previously treated for Cushing\u2019s disease. Clin Endocrinol (Oxf) 60(5):550\u2013559","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"716_CR30","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1530\/EJE-09-0836","volume":"162","author":"C Hoybye","year":"2010","unstructured":"Hoybye C, Ragnarsson O, Jonsson PJ, Koltowska-Haggstrom M, Trainer P, Feldt-Rasmussen U, Biller BM (2010) Clinical features of GH deficiency and effects of 3\u00a0years of GH replacement in adults with controlled Cushing\u2019s disease. Eur J Endocrinol 162(4):677\u2013684","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"716_CR31","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000095168","volume":"66","author":"A Colson","year":"2006","unstructured":"Colson A, Brooke AM, Walker D, Besser GM, Chew SL, Grossman AB, Jenkins PJ, Drake WM, Monson JP (2006) Growth hormone deficiency and replacement in patients with treated Cushing\u2019s disease, prolactinomas and non-functioning pituitary adenomas: effects on body composition, glucose metabolism, lipid status and bone mineral density. Horm Res 66(6):257\u2013267","journal-title":"Horm Res"},{"issue":"7","key":"716_CR32","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1210\/jc.2007-2673","volume":"93","author":"LL Norrman","year":"2008","unstructured":"Norrman LL, Johannsson G, Sunnerhagen KS, Svensson J (2008) Baseline characteristics and the effects of two years of growth hormone (GH) replacement therapy in adults with GH deficiency previously treated for acromegaly. J Clin Endocrinol Metab 93(7):2531\u20132538","journal-title":"J Clin Endocrinol Metab"},{"key":"716_CR33","doi-asserted-by":"crossref","unstructured":"(1998) Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency. J Clin Endocrinol Metab 83(2):379\u2013381","DOI":"10.1210\/jc.83.2.379"},{"issue":"4","key":"716_CR34","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1530\/EJE-10-0914","volume":"164","author":"IC Nieuwpoort van","year":"2011","unstructured":"van Nieuwpoort IC, van Bunderen CC, Arwert LI, Franken AA, Koppeschaar HP, van der Lelij AJ, Twisk JW, Boers M, Drent ML (2011) Dutch National Registry of GH Treatment in Adults: patient characteristics and diagnostic test procedures. Eur J Endocrinol 164(4):491\u2013497","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"716_CR35","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1089\/jwh.2008.0897","volume":"18","author":"MC Buencamino","year":"2009","unstructured":"Buencamino MC, Sikon AL, Jain A, Thacker HL (2009) An observational study on the adherence to treatment guidelines of osteopenia. J Womens Health (Larchmt) 18(6):873\u2013881","journal-title":"J Womens Health (Larchmt)"},{"issue":"3","key":"716_CR36","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1046\/j.1365-2265.2003.01713.x","volume":"58","author":"C Somma Di","year":"2003","unstructured":"Di Somma C, Pivonello R, Loche S, Faggiano A, Klain M, Salvatore M, Lombardi G, Colao A (2003) Effect of 2\u00a0years of cortisol normalization on the impaired bone mass and turnover in adolescent and adult patients with Cushing\u2019s disease: a prospective study. Clin Endocrinol (Oxf) 58(3):302\u2013308","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"716_CR37","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s11102-005-1051-2","volume":"7","author":"T Mancini","year":"2004","unstructured":"Mancini T, Doga M, Mazziotti G, Giustina A (2004) Cushing\u2019s syndrome and bone. Pituitary 7(4):249\u2013252","journal-title":"Pituitary"},{"issue":"4","key":"716_CR38","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.tem.2006.03.009","volume":"17","author":"G Mazziotti","year":"2006","unstructured":"Mazziotti G, Angeli A, Bilezikian JP, Canalis E, Giustina A (2006) Glucocorticoid-induced osteoporosis: an update. Trends Endocrinol Metab 17(4):144\u2013149","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"716_CR39","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1530\/EJE-10-0125","volume":"163","author":"G Mazziotti","year":"2010","unstructured":"Mazziotti G, Porcelli T, Bianchi A, Cimino V, Patelli I, Mejia C, Fusco A, Giampietro A, De ML, Giustina A (2010) Glucocorticoid replacement therapy and vertebral fractures in hypopituitary adult males with GH deficiency. Eur J Endocrinol 163(1):15\u201320","journal-title":"Eur J Endocrinol"},{"issue":"Suppl 2","key":"716_CR40","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1007\/s00586-003-0613-0","volume":"12","author":"M Grigoryan","year":"2003","unstructured":"Grigoryan M, Guermazi A, Roemer FW, Delmas PD, Genant HK (2003) Recognizing and reporting osteoporotic vertebral fractures. Eur Spine J 12(Suppl 2):S104\u2013S112","journal-title":"Eur Spine J"},{"issue":"7","key":"716_CR41","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1359\/JBMR.050314","volume":"20","author":"HA Fink","year":"2005","unstructured":"Fink HA, Milavetz DL, Palermo L, Nevitt MC, Cauley JA, Genant HK, Black DM, Ensrud KE (2005) What proportion of incident radiographic vertebral deformities is clinically diagnosed and vice versa? J Bone Miner Res 20(7):1216\u20131222","journal-title":"J Bone Miner Res"},{"key":"716_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2831","author":"KE Ensrud","year":"2016","unstructured":"Ensrud KE, Blackwell TL, Fink HA, Zhang J, Cauley JA, Cawthon PM, Black DM, Bauer DC, Curtis JR, Orwoll ES, Barrett-Connor E, Kado DM, Marshall LM, Shikany JM, Schousboe JT (2016) What proportion of incident radiographic vertebral fractures in older men is clinically diagnosed and vice versa: a prospective study. J Bone Miner Res. doi: 10.1002\/jbmr.2831","journal-title":"J Bone Miner Res"},{"issue":"1","key":"716_CR43","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11102-007-0069-z","volume":"11","author":"G Mazziotti","year":"2008","unstructured":"Mazziotti G, Bianchi A, Cimino V, Bonadonna S, Martini P, Fusco A, De ML, Giustina A (2008) Effect of gonadal status on bone mineral density and radiological spinal deformities in adult patients with growth hormone deficiency. Pituitary 11(1):55\u201361","journal-title":"Pituitary"},{"issue":"6","key":"716_CR44","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1530\/EJE-14-0097","volume":"170","author":"G Mazziotti","year":"2014","unstructured":"Mazziotti G, Mormando M, Cristiano A, Bianchi A, Porcelli T, Giampietro A, Maffezzoni F, Serra V, De ML, Giustina A (2014) Association between l-thyroxine treatment, GH deficiency, and radiological vertebral fractures in patients with adult-onset hypopituitarism. Eur J Endocrinol 170(6):893\u2013899","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"716_CR45","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s11102-009-0186-y","volume":"12","author":"AA Klaauw van der","year":"2009","unstructured":"van der Klaauw AA, Bax JJ, Roelfsema F, Stokkel MPM, Bleeker GB, Biermasz NR, Smit JWA, Romijn JA, Pereira AM (2009) Limited effects of growth hormone replacement in patients with GH deficiency during long-term cure of acromegaly. Pituitary 12(4):339\u2013346","journal-title":"Pituitary"},{"issue":"Suppl 1","key":"716_CR46","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1007\/BF01673397","volume":"53","author":"C Cooper","year":"1993","unstructured":"Cooper C (1993) The epidemiology of fragility fractures: is there a role for bone quality? Calcif Tissue Int 53(Suppl 1):S23\u2013S26","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"716_CR47","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1046\/j.1365-2362.2002.00944.x","volume":"32","author":"T Ueland","year":"2002","unstructured":"Ueland T, Ebbesen EN, Thomsen JS, Mosekilde L, Brixen K, Flyvbjerg A, Bollerslev J (2002) Decreased trabecular bone biomechanical competence, apparent density, IGF-II and IGFBP-5 content in acromegaly. Eur J Clin Invest 32(2):122\u2013128","journal-title":"Eur J Clin Invest"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-016-0716-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11102-016-0716-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-016-0716-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T04:31:44Z","timestamp":1567744304000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11102-016-0716-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,5]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["716"],"URL":"https:\/\/doi.org\/10.1007\/s11102-016-0716-3","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,5]]}}}